Aspiriant, LLC Johnson & Johnson Transaction History

Aspiriant, LLC

$2.45 Billion
Q2 2024

A detailed history of Aspiriant, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Aspiriant, LLC holds 21,126 shares of JNJ stock, worth $3.51 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

21,126

Previous 23,799 11.23%

Holding current value

$3.51 Million

Previous $3.76 Million 17.99%

% of portfolio

0.13%

Previous 0.16%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$144.38 - $157.78 $385,927 - $421,745	-2,673 Reduced 11.23%	21,126 $3.09 Million
Q1 2024 Apr 15, 2024	BUY	$155.22 - $162.74 $127,435 - $133,609	821 Added 3.57%	23,799 $3.76 Million
Q4 2023 Jan 26, 2024	BUY	$145.6 - $158.88 $25,771 - $28,121	177 Added 0.78%	22,978 $3.6 Million
Q3 2023 Oct 17, 2023	SELL	$155.75 - $174.48 $34,888 - $39,083	-224 Reduced 0.97%	22,801 $3.55 Million
Q2 2023 Jul 19, 2023	SELL	$154.35 - $166.11 $44,607 - $48,005	-289 Reduced 1.24%	23,025 $3.81 Million
Q1 2023 Apr 27, 2023	SELL	$151.05 - $180.26 $181,411 - $216,492	-1,201 Reduced 4.9%	23,314 $3.61 Million
Q4 2022 Jan 23, 2023	BUY	$160.2 - $179.79 $156,355 - $175,475	976 Added 4.15%	24,515 $0
Q3 2022 Oct 28, 2022	SELL	$161.33 - $179.52 $51,625 - $57,446	-320 Reduced 1.34%	23,539 $3.85 Million
Q2 2022 Jul 25, 2022	SELL	$168.19 - $186.01 $142,625 - $157,736	-848 Reduced 3.43%	23,859 $4.23 Million
Q1 2022 May 06, 2022	SELL	$158.14 - $179.59 $118,763 - $134,872	-751 Reduced 2.95%	24,707 $4.38 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $325,114 - $360,725	2,085 Added 8.92%	25,458 $4.36 Million
Q3 2021 Oct 27, 2021	SELL	$161.5 - $179.47 $63,954 - $71,070	-396 Reduced 1.67%	23,373 $3.77 Million
Q2 2021 Aug 13, 2021	SELL	$159.48 - $171.07 $28,706 - $30,792	-180 Reduced 0.75%	23,769 $3.92 Million
Q1 2021 May 11, 2021	BUY	$153.07 - $170.48 $26,787 - $29,834	175 Added 0.74%	23,949 $3.93 Million
Q4 2020 Feb 01, 2021	SELL	$137.11 - $157.38 $731,481 - $839,622	-5,335 Reduced 18.33%	23,774 $3.74 Million
Q3 2020 Oct 29, 2020	BUY	$140.38 - $153.83 $605,458 - $663,468	4,313 Added 17.39%	29,109 $4.33 Million
Q2 2020 Aug 06, 2020	SELL	$128.81 - $155.51 $1.55 Million - $1.87 Million	-12,052 Reduced 32.71%	24,796 $3.49 Million
Q1 2020 May 05, 2020	BUY	$111.14 - $153.99 $1.5 Million - $2.08 Million	13,477 Added 57.67%	36,848 $4.83 Million
Q4 2019 Jan 27, 2020	SELL	$127.5 - $146.44 $655,350 - $752,701	-5,140 Reduced 18.03%	23,371 $3.41 Million
Q3 2019 Nov 04, 2019	SELL	$126.95 - $142.14 $1.57 Million - $1.76 Million	-12,397 Reduced 30.3%	28,511 $3.69 Million
Q2 2019 Aug 06, 2019	SELL	$131.15 - $144.24 $193,052 - $212,321	-1,472 Reduced 3.47%	40,908 $5.69 Million
Q1 2019 May 03, 2019	BUY	$125.72 - $139.79 $1.09 Million - $1.21 Million	8,689 Added 25.79%	42,380 $5.91 Million
Q4 2018 Feb 04, 2019	SELL	$122.84 - $147.84 $185,488 - $223,238	-1,510 Reduced 4.29%	33,691 $4.35 Million
Q3 2018 Oct 26, 2018	SELL	$121.58 - $142.88 $1.41 Million - $1.65 Million	-11,567 Reduced 24.73%	35,201 $4.87 Million
Q2 2018 Aug 07, 2018	SELL	$119.4 - $131.76 $279,276 - $308,186	-2,339 Reduced 4.76%	46,768 $5.68 Million
Q1 2018 May 04, 2018	BUY	$125.1 - $148.14 $3.99 Million - $4.72 Million	31,892 Added 185.26%	49,107 $6.29 Million
Q4 2017 Jan 31, 2018	SELL	$131.22 - $143.62 $3.92 Million - $4.29 Million	-29,867 Reduced 63.44%	17,215 $2.41 Million
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $6.1 Million - $6.37 Million	47,082	47,082 $6.12 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspiriant, LLC with notifications on news.

Account